In diffuse large B-cell lymphoma (DLBCL), ETS1 modulates B-cell signaling, differentiation, and immune-related genes, with FCMR identified as a novel target that promotes lymphomagenesis. Here, ETS1 is linked to diffuse large B-cell lymphoma.